Literature DB >> 25739660

Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.

Aihua Zhang1, Hui Sun1, Guangli Yan1, Ping Wang1, Xijun Wang1.   

Abstract

Mass spectrometry-based metabolomics has become increasingly popular in molecular medicine. High-definition mass spectrometry (MS), coupled with pattern recognition methods, have been carried out to obtain comprehensive metabolite profiling and metabolic pathway of large biological datasets. This sets the scene for a new and powerful diagnostic approach. Analysis of the key metabolites in body fluids has become an important part of improving disease diagnosis. With technological advances in analytical techniques, the ability to measure low-molecular-weight metabolites in bio-samples provides a powerful platform for identifying metabolites that are uniquely correlated with a specific human disease. MS-based metabolomics can lead to enhanced understanding of disease mechanisms and to new diagnostic markers and has a strong potential to contribute to improving early diagnosis of diseases. This review will highlight the importance and benefit with certain characteristic examples of MS-metabolomics for identifying metabolic pathways and metabolites that accurately screen for potential diagnostic biomarkers of diseases.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  biomarker; mass spectrometry; metabolic pathway; metabolite; metabolomics

Mesh:

Substances:

Year:  2015        PMID: 25739660     DOI: 10.1002/bmc.3453

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  53 in total

1.  Serum Metabolomics Based on GC-MS Reveals the Antipyretic Mechanism of Ellagic Acid in a Rat Model.

Authors:  Fengfeng Xie; Liba Xu; Hua Zhu; Yinlan Li; Lizhen Nong; Yaling Chen; Yanfang Zeng; Sijie Cen
Journal:  Metabolites       Date:  2022-05-25

2.  Metabolic Alterations in Sputum and Exhaled Breath Condensate of Early Stage Non-Small Cell Lung Cancer Patients After Surgical Resection: A Pilot Study.

Authors:  Naseer Ahmed; Biniam Kidane; Le Wang; Zoann Nugent; Nataliya Moldovan; April McElrea; Shiva Shariati-Ievari; Gefei Qing; Lawrence Tan; Gordon Buduhan; Sadeesh K Srinathan; Renelle Meyers; Michel Aliani
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

3.  In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Ana Margarida Araújo; Márcia Carvalho; Vera Marisa Costa; José Alberto Duarte; Ricardo Jorge Dinis-Oliveira; Maria de Lourdes Bastos; Paula Guedes de Pinho; Félix Carvalho
Journal:  Arch Toxicol       Date:  2020-11-19       Impact factor: 5.153

4.  A metabolomic study for chronic heart failure patients based on a dried blood spot mass spectrometry approach.

Authors:  Gaowa Zhao; Dong Cheng; Yu Wang; Yalan Cao; Shuting Xiang; Qin Yu
Journal:  RSC Adv       Date:  2020-05-22       Impact factor: 4.036

5.  High-throughput lipidomics reveal mirabilite regulating lipid metabolism as anticancer therapeutics.

Authors:  Hong-Lian Zhang; Ai-Hua Zhang; Xiao-Hang Zhou; Hui Sun; Xiang-Qian Wang; Liu Liang; Xi-Jun Wang
Journal:  RSC Adv       Date:  2018-10-18       Impact factor: 4.036

Review 6.  Metaproteomics as a Complementary Approach to Gut Microbiota in Health and Disease.

Authors:  Bernardo A Petriz; Octávio L Franco
Journal:  Front Chem       Date:  2017-01-26       Impact factor: 5.221

7.  Effects of Dufulin on Oxidative Stress and Metabolomic Profile of Tubifex.

Authors:  Yile Yu; Yuxin Zhu; Jing Yang; Wentao Zhu; Zhiqiang Zhou; Renke Zhang
Journal:  Metabolites       Date:  2021-06-11

8.  Study on Urinary Candidate Metabolome for the Early Detection of Breast Cancer.

Authors:  Faten Zahran; Ramzy Rashed; Mohamed Omran; Hossam Darwish; Arafa Belal
Journal:  Indian J Clin Biochem       Date:  2020-06-27

Review 9.  Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders.

Authors:  Sumit Sethi; Elisa Brietzke
Journal:  Int J Neuropsychopharmacol       Date:  2015-10-09       Impact factor: 5.176

Review 10.  Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases.

Authors:  Akram Safaei; Afsaneh Arefi Oskouie; Seyed Reza Mohebbi; Mostafa Rezaei-Tavirani; Mohammad Mahboubi; Maryam Peyvandi; Farshad Okhovatian; Mona Zamanian-Azodi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.